Log in to save to my catalogue

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1931710611

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

About this item

Full title

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Gastroenterology & hepatology, 2017-11, Vol.14 (11), p.641-651

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
HCV prevalence and incidence among people who inject drugs (PWID) remains high
Direct-acting antiviral agents (DAA) for HCV with cure in >95% provide a tool for addressing HCV-related liver-disease burden among PWID
Adherence and response to DAA therapy among people receiving opioid substitution therapy (OST), including those wi...

Alternative Titles

Full title

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1931710611

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1931710611

Other Identifiers

ISSN

1759-5045

E-ISSN

1759-5053

DOI

10.1038/nrgastro.2017.106

How to access this item